Congruence Therapeutics ("Congruence"), a clinical-stage, computationally driven biotechnology company building a pipeline of ...
To understand how an organization functions, you must analyze its dynamics and performance. The benefit of using a congruence model for this analysis is that it divides the analysis into four parts ...
Columbia University professors David A. Nadler and Michael L. Tushman developed the congruence model for businesses. This model offers a structured approach to analyzing the key drivers of ...
MONTREAL, March 19, 2026 /PRNewswire/ -- Congruence Therapeutics today announced that the first participant has been dosed in its Phase 1/1b clinical trial evaluating CGX-926, an oral small-molecule ...
- Programs in Parkinson's Disease and Alpha-1 antitrypsin deficiency progressing toward the clinic - MONTREAL, March 19, 2026 /PRNewswire/ -- Congruence Therapeutics, a clinical-stage, computationally ...
OSAKA, Japan and MONTREAL, March 2, 2026 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; "Ono") and Congruence Therapeutics today announced ...
MONTREAL, Oct. 23, 2026 /PRNewswire/ -- Congruence Therapeutics ("Congruence"), a clinical-stage, computationally driven biotechnology company building a pipeline of pharmacological correctors for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results